Inotiv (NOTV) to Release Earnings on Friday

Inotiv (NASDAQ:NOTVGet Free Report) is scheduled to announce its earnings results before the market opens on Friday, May 10th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Inotiv has set its FY 2024 guidance at EPS.Investors interested in participating in the company’s conference call can do so using this link.

Inotiv (NASDAQ:NOTVGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported ($0.60) EPS for the quarter, missing the consensus estimate of $0.07 by ($0.67). Inotiv had a negative return on equity of 10.99% and a negative net margin of 5.67%. The business had revenue of $135.50 million during the quarter, compared to the consensus estimate of $136.26 million. On average, analysts expect Inotiv to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inotiv Price Performance

NASDAQ NOTV opened at $4.16 on Friday. Inotiv has a one year low of $1.61 and a one year high of $11.42. The stock has a 50-day moving average of $7.35 and a 200 day moving average of $4.66. The company has a market capitalization of $107.29 million, a price-to-earnings ratio of -3.20 and a beta of 3.37. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.28 and a current ratio of 1.74.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised Inotiv from a “hold” rating to a “buy” rating and raised their target price for the stock from $3.00 to $11.50 in a research report on Friday, February 9th.

Get Our Latest Report on Inotiv

About Inotiv

(Get Free Report)

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.

Read More

Earnings History for Inotiv (NASDAQ:NOTV)

Receive News & Ratings for Inotiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inotiv and related companies with MarketBeat.com's FREE daily email newsletter.